Turnover€0
EBIT margin—
Net result€13k-56.9%
Working capital€8k
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of FOXY is 1.1% (low). The 2023 annual accounts show equity of €133k and a net result of €13k. Equity is growing by ~26.7% per year across the filed fiscal years. Its solvency ranks better than 75% of 40 sector peers (fiscal year 2023). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 5 annual accounts.
Financials
FY 2023
€133k
equity
Turnover—
Net result€13kHealth81/100 · Excellent
See full annual accounts
People & board
No director data processed yet.
To directors Publicationslatest 25-01-2024
1
publications in the State GazettePublication in the Belgian Official Gazette — Minor changeAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2018 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.1%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Annual accounts: weaker financial profile
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | FOXY |
Registered office
Mont-le-Soie 1
6698 Vielsalm, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.